Scroll

Drugging the Undruggables

First-in-Class Therapeutics based on Novel Science

First-in-Class Therapeutics based on Novel Science

Drugging the Undruggables

PIPELINE

Innovative Therapeutic

First-in-class anticancer agents capable of intergrated control of resistant cancer

Cancer Stemness
Blocking Agents

Next-Generation
Immunotherapeutic
Agents

IBD therapeutics

  • Cancer Stemness
    Blocking Agents

  • Next-Generation
    Immunotherapeutic
    Agents

  • IBD therapeutics

PLATFORM TECHNOLOGY

Drugging Informatics™

Generation of first-in-class therapeutics for better life

VIEW MORE

MERIT

Innovations from Experiences & Collaborations

Proprietary Platform Technology
Continuous generation of first-in-class drugs
Patient-Centered Discovery Strategy
Focusing on the solution for “unmet medical needs”
Experienced Leadership
Proven track records in whole cycle of drug discovery & development
Open Innovation
Collaboration with experts